Primary Care Flashcards
FEV1:FVC ratio of what indicates COPD
< 70% or 0.7
Stages of COPD based on predicted FEV1 %
Stage 1: >80%
Stage 2: 50-79%
Stage 3: 30-49%
Stage 4: < 30%
MRC Dyspnoea Scale Grade 1
Not troubled by SOB except on strenuous exercise
MRC Dyspnoea Scale Grade 2
SOB when walking quickly or uphill
MRC Dyspnoea Scale Grade 3
Walks slower than contemporaries
Has to stop due to SOB
MRC Dyspnoea Scale Grade 4
Stops for breath after 100m
MRC Dyspnoea Scale Grade 5
Too breathless to leave home
Breathless when dressing
Target PaO2 for COPD patients
8KPa
Requirements for long-term O2 therapy in COPD?
Non-smokers with a PaO2 < 7.3KPa
OR
Secondary polycythaemia, Peripheral oedema, Pulmonary Hypotension
Prophylactic antibiotics for COPD
Azithromycin 250mg 3x weekly
Paroxysmal AF
2+ episodes lasting 30 seconds to 7 days
Persistent AF
Continuous for 7+ days
Long standing persistent AF if 12+ months
Permanent AF
Long-standing persistent and resistant to treatment
When should Amiodarone be used following electrical cardioversion in AF?
4 months before, and for 12 months afterwards
What level of NT-proBNP in heart failure requires a referral?
400-2000ng/L
What factors may decrease NT-proBNP?
Obesity
Afro-Caribbean ethnicity
Diuretics, ACEi, Beta Blocker use
NYHA Classification of Heart Failure
- No limitations
- Slight physical limitations
- Marked limitations
- Symptoms at rest
When should electrical cardioversion be offered in AF?
Patients who have had AF persisting for 48 hours of longer
Transoesophageal echocardiography-guided cardioversion OR conventional cardioversion deemed equally efficacious
Indications for pharmacological rate control in AF (Beta blocker/ digoxin/ Diltiazem)
AF with a reversible cause
Patient has heart failure caused by AF
New onset AF
Atrial flutter suitable for ablation
Risks of AF with stroke
Larger infarcts Increased disability Death Long-term care Impaired cognitive function Dementia
Anti-arrhythmic drugs for AF
Beta-blockers
Flecainide, propafenone (pill in the pocket vs regular)
Sotalol, dronedarone, amiodarone
When to cardiovert in an emergency AF presentation
Acute new onset AF with haemodynamic instability
Principles of lifestyle management in heart failure
Food- salt restriction, fluid restriction if hyponatraemic, alcohol intake Smoking Yearly influenza vaccinations Driving e.g. LGV, minibus licenses Air travel- may be affected Pregnancy and contraception
Which Heart failure patients should be offered a loop diuretic?
Those with preserved LVEF ( greater than 40%)
e.g. Furosemide 80mg OD
Secondary causes of hypertension
Renal disease (mostly intrinsic) Endocrine (Cushing's, Conn's Phaeochromocytoma, Acromegaly, Hyperparathyroidism Pregnancy Coarctation of the aorta Steroids MAOIs
Stage 1 Hypertension and management
BP 140/90 mmHg
(5 less for ambulatory monitoring)
Lifestyle management alone initially
Stage 2 Hypertension
BP 160/100 mmHg
(5 less for ambulatory monitoring)
Start with ACEi or CCB therapy
Indications for pharmacological management of Stage 1 hypertension
Under 80 with:
- Target organ damage
- Diabetes
- Renal disease
- QRISK2 20% +
Thiazide like diuretics
e.g. Bendroflumethiazide, Indapamide, Chlortalidone
Best taken in the morning as this has best diuretic effect
Avoid in gout, hypokalaemia, hyponatraemia
ECG changes that may be seen in stable angina
Pathological Q waves
ST depression
T wave inversion
LBBB
Initial treatment for Stable Angina
GTN spray +
Beta blocker or CCB
Additional drug treatments for Stable Angina
Long acting nitrates
Ivabradine (cardiotonic agent)
Nicorandil (vasodilator)
Ranolazine